Skip to main content
Samsung Galaxy Watch Detects Fainting Episodes Five Minutes Early
Back to AI NewsNews

Samsung Galaxy Watch Detects Fainting Episodes Five Minutes Early

A clinical study found Samsung's Galaxy Watch6 predicts fainting episodes up to five minutes in advance with 84.6% accuracy.

cueball EditorialFriday, 8 May 2026 4 min read

What Happened

Samsung has announced that its Galaxy Watch6 smartwatch demonstrated the ability to predict fainting episodes up to five minutes before they occur, according to findings from a clinical study conducted with Chung-Ang University. The study reported an accuracy rate of 84.6 percent.

Background

Fainting, clinically known as syncope, occurs when blood flow to the brain drops suddenly, causing a temporary loss of consciousness. It can result from a range of conditions including cardiovascular irregularities, dehydration, and autonomic nervous system dysfunction. For individuals with recurrent syncope, advance warning of even a few minutes can provide time to sit or lie down, potentially preventing injuries from falls.

Samsung's Galaxy Watch line has steadily expanded its health monitoring capabilities in recent years. The Galaxy Watch6, released as part of the company's 2023 wearable lineup, includes sensors capable of tracking heart rate, blood oxygen levels, and electrical signals from the skin. The company has positioned its wearable health features as a differentiator against competitors including Apple, Fitbit, and Garmin.

The study was conducted in collaboration with Chung-Ang University, a research institution based in Seoul, South Korea. Details about the study's sample size, methodology, and peer review status were not included in the available wire report.

What the Device Does

According to the announcement, the Galaxy Watch6 analyzes physiological signals to identify patterns that precede a fainting episode. The device generates an alert up to five minutes before the predicted event, giving the wearer time to respond.

The reported accuracy figure of 84.6 percent refers to the watch's ability to correctly identify impending fainting events during the clinical study. The wire report did not specify the false positive rate, meaning how often the device issues a warning when no fainting episode occurs, nor did it detail the number of participants or the duration of the study period.

Context: Wearables and Predictive Health Monitoring

Predictive health monitoring has become an active area of development across the consumer wearables market. Apple's Apple Watch has received regulatory clearance in the United States for features including atrial fibrillation detection and fall detection. Samsung has pursued similar regulatory pathways for select health features on its Galaxy Watch devices in various markets.

The distinction between a consumer wellness feature and a regulated medical device is significant in the wearables industry. Features that make clinical diagnostic claims typically require clearance from health regulators such as the U.S. Food and Drug Administration or equivalent bodies in other jurisdictions before they can be marketed as medical tools.

The wire report did not state whether Samsung has submitted the fainting prediction feature for regulatory review in any market, or whether the feature is currently available on existing Galaxy Watch6 units via a software update or is planned for a future device.

What It Means in Practice

If validated through peer-reviewed research and cleared by relevant health regulators, a five-minute advance warning for fainting could be clinically relevant for patients managing conditions associated with recurrent syncope. Physicians and cardiologists who monitor patients with such conditions currently rely primarily on implantable loop recorders and Holter monitors for continuous cardiac data collection. A consumer wearable capable of providing comparable early warning signals could expand monitoring options.

However, the wire report does not indicate that Samsung or Chung-Ang University has published the full study findings in a peer-reviewed medical journal, and no regulatory submissions or clearances were referenced.

What Happens Next

Samsung has not announced a public release date for the fainting prediction feature or indicated whether it will be available as a software update to existing Galaxy Watch6 devices or integrated into future hardware.

Get our editors' take on what it all means. Read the Editor's Blog →